Vedolizumab Treatment of Refractory Immune Checkpoint Inhibitor Colitis

被引：0
|
作者：
McNally, Bridgette B. [1 ]
Sivakumar, Angiela [1 ]
Haddad, Nael [2 ]
Suchartlikitwong, Sakolwan [1 ]
Aguon, Paul Muna [1 ]
Fung, Brian M. [1 ]
Zucker, Kelly [1 ]
David, Joseph [1 ]
机构：
[1] Univ Arizona, Coll Med, Phoenix, AZ USA
[2] Univ Arizona, Phoenix, AZ USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2021年 / 116卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S1696
引用
收藏
页码：S756 / S756
页数：1
相关论文
共 50 条
  • [31] Recurrent Checkpoint Inhibitor Colitis Complicated by Treatment Induced Liver Injury Requiring Vedolizumab Therapy
    Huang, Sarah
    Rahman, Aruni
    Shama, Naureen
    Castillo, Michael
    Mobin, Navim
    Quintero, Samuel
    Bekele, Ezana
    Grosman, Irvin
    Weisberg, Ilan
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S1717 - S1718
  • [32] Role of 5-Aminosalicylates in Steroid-Refractory Immune Checkpoint Inhibitor Colitis
    Ginnaram, Shravya
    Marrache, Kyle
    Elrod, Sarah
    Nugooru, Sudeep
    Khan, Maria
    Tzarnas, Stephanie
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S1634 - S1634
  • [33] A case of refractory immune checkpoint inhibitor-induced colitis with Clostridioides difficile infection
    Okura, Yukito
    Kobayashi, Katsumasa
    Yamada, Yurina
    Furuya, Makoto
    Kitano, Naoki
    Oshina, Eri
    Matsuoka, Mana
    Nozaka, Takahito
    Tashiro, Yoshihiro
    Sato, Ayako
    Yauchi, Masato
    Matsumoto, Taichi
    Furumoto, Yohei
    Asano, Toru
    Azuma, Seishin
    DEN OPEN, 2023, 3 (01):
  • [34] Is chronic refractory colitis from immune checkpoint inhibitor associated with good cancer outcome?
    Ma, Weijie
    Thomas, Anusha
    Wang, Yinghong
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [35] Refractory Immune Checkpoint Inhibitor-Induced Colitis Improved by Tacrolimus: A Case Report
    Kunogi, Yasuhito
    Tominaga, Keiichi
    Abe, Keiichiro
    Kanazawa, Mimari
    Tanaka, Takanao
    Watanabe, Shoko
    Kondo, Masayuki
    Kanamori, Akira
    Iijima, Makoto
    Goda, Kenichi
    Nozawa, Yumi
    Ishida, Kazuyuki
    Irisawa, Atsushi
    HEALTHCARE, 2021, 9 (04)
  • [36] Back to the Basics: Use Of Budesonide as the Treatment for Immune Checkpoint Inhibitor Induced Microscopic Colitis Non-Responsive to Prednisone, Infliximab, and Vedolizumab
    Kovach, Zach
    Shepherd, Katherine
    Cohen, Ethan M.
    Adekolu, Ayowumi
    Tandon, Kanwarpreet
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S2002 - S2002
  • [37] Treatment of immune checkpoint inhibitor-related colitis: a narrative review
    Wang, Shiyang
    Wang, Hanping
    TRANSLATIONAL CANCER RESEARCH, 2024, 13 (12) : 7002 - 7014
  • [38] Check this out: treatment paradigms in immune-checkpoint inhibitor colitis
    Kiparizoska, Sara
    Murphy, Megan E.
    Mattar, Mark C.
    CURRENT OPINION IN GASTROENTEROLOGY, 2023, 39 (01) : 43 - 49
  • [39] Use of Vedolizumab in Immune Checkpoint Inhibitor-associated Enterocolitis
    Stone, Molly L.
    Forster, Erin M.
    INFLAMMATORY BOWEL DISEASES, 2021, 27 (12) : E147 - E147
  • [40] FMT Combined with Vedolizumab for the Treatment of Refractory Ulcerative Colitis
    Chen, Lanfang
    Peng, Juan
    Wang, Yanwei
    Liu, Yuzhi
    Fu, Xiangsheng
    Li, Jun
    DIGESTIVE DISEASES AND SCIENCES, 2024, 69 (11) : 4006 - 4008
12345